These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 4940648

  • 1. On the usefulness of the placebo and of the double-blind technique in the evaluation of psychotropic drugs.
    Tétreault L, Bordeleau JM.
    Psychopharmacol Bull; 1971 Jul; 7(3):44-64. PubMed ID: 4940648
    [No Abstract] [Full Text] [Related]

  • 2. [Some problems posed by double-blind investigation of psychotropic drugs: clinical trial of Nobrium Roche].
    Chistoni GC.
    Schweiz Arch Neurol Neurochir Psychiatr; 1971 Jul; 108(2):309-15. PubMed ID: 4941608
    [No Abstract] [Full Text] [Related]

  • 3. [Usefulness of placebos and of double-blind technic in the evaluation of psychotropic drugs].
    Tétreault L, Bordeleau JM.
    Encephale; 1970 Jul; 59(3):5-24. PubMed ID: 4987153
    [No Abstract] [Full Text] [Related]

  • 4. [Psychopharmacology and clinical psychotherapy].
    Zauner J.
    Z Psychosom Med Psychoanal; 1974 Jul; 20(2):127-37. PubMed ID: 4844076
    [No Abstract] [Full Text] [Related]

  • 5. [Longitudinal profiles of the effects of psychotropic drugs from clinico-methodological viewpoint].
    Helmchen H, Müller-Oerlinghausen B.
    Arzneimittelforschung; 1974 Jul; 24(7):976-80. PubMed ID: 4603668
    [No Abstract] [Full Text] [Related]

  • 6. A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients.
    Small JG, Kellams JJ, Milstein V, Moore J.
    Am J Psychiatry; 1975 Dec; 132(12):1315-7. PubMed ID: 1106217
    [Abstract] [Full Text] [Related]

  • 7. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL, Vereecken JL.
    Psychiatr Neurol Neurochir; 1973 Dec; 76(1):47-59. PubMed ID: 4699105
    [No Abstract] [Full Text] [Related]

  • 8. [Placebo and placebo-effects in the clinic and research].
    Schindel L.
    Arzneimittelforschung; 1967 Jul; 17(7):892-917. PubMed ID: 4885152
    [No Abstract] [Full Text] [Related]

  • 9. [Difficulties of evaluation of the results of drug treatment of schizophrenia].
    Welbel L.
    Psychiatr Pol; 1980 Jul; 14(1):51-7. PubMed ID: 6102774
    [No Abstract] [Full Text] [Related]

  • 10. Placebos in clinical practice and the power of suggestion.
    Vernillo A.
    Am J Bioeth; 2009 Dec; 9(12):32-3. PubMed ID: 20013496
    [No Abstract] [Full Text] [Related]

  • 11. [Methods and problems of clinical psychopharmacology. Results of a double blind study with Medazepam and placebo in geriatirc psychiatry].
    Bergener M, Undeutsch D.
    Arzneimittelforschung; 1968 Dec; 18(12):1563-6. PubMed ID: 4887291
    [No Abstract] [Full Text] [Related]

  • 12. The design of drug trials with neurotic patients.
    Kellner R.
    Behav Neuropsychiatry; 1970 Dec; 2(1):12-9. PubMed ID: 4913956
    [No Abstract] [Full Text] [Related]

  • 13. [Placebos and double-blind studies: significant differences].
    Schelling JL.
    Rev Med Suisse Romande; 1969 Sep; 89(9):905-9. PubMed ID: 4921157
    [No Abstract] [Full Text] [Related]

  • 14. Placebo usage in clinical trials of life-saving drugs.
    Prog Clin Biol Res; 1980 Sep; 38():257-60. PubMed ID: 7384131
    [No Abstract] [Full Text] [Related]

  • 15. The use of tybamate in psychotic patients. (A further double blind study).
    Meshel E, Denber HC.
    Dis Nerv Syst; 1968 Apr; 29(4):243-5. PubMed ID: 4870945
    [No Abstract] [Full Text] [Related]

  • 16. [Psychopharmacologic treatment of cardiac neurotic patients with dipotassium chlorazepate in double-blind test].
    Schüffel W, Schaumburg C, Schäfer N.
    Arzneimittelforschung; 1970 Jan; 20(1):127-30. PubMed ID: 4909438
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A double blind study of clomacran.
    Lampe WT.
    Curr Ther Res Clin Exp; 1969 May; 11(5):300-6. PubMed ID: 4977403
    [No Abstract] [Full Text] [Related]

  • 19. [The neuropsychopharmacological drugs in dentistry: clinical-experimental study].
    Bernardini UD, Huober G, Pini Prato G.
    Riv Ital Stomatol; 1969 Oct; 24(10):993-1000. PubMed ID: 4909760
    [No Abstract] [Full Text] [Related]

  • 20. Clinical psychopharmacology in its 20th year. Late, unanticipated effects of neuroleptics may limit their use in psychiatry.
    Crane GE.
    Science; 1973 Jul 13; 181(4095):124-8. PubMed ID: 4711733
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.